X-linked Hypohidrotic Ectodermal Dysplasia clinical trials at UCSF
1 in progress, 0 open to new patients
-
Extension Study of XLHED-Affected Male Subjects Treated With EDI200 in Protocol ECP-002
Sorry, in progress, not accepting new patients
The goal of the ECP-002e extension study is to continue the evaluation of all EDI200-treated ECP-002 subjects up to age 10 yrs. No additional study drug administration is planned. The efficacy evaluations will incorporate growth and development parameters, frequency of infections and hospitalizations, and age-appropriate assessments of ectoderm-derived organ function. The safety evaluations will include physical examinations, adverse events and concomitant medication documentation, and laboratory testing. Funding Source - FDA OOPD
San Francisco, California and other locations